Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Mitomycin C
Mitomycin C 2 mg Injection is an essential chemotherapeutic agent designed for the effective management of various cancers, including those of the pancreas, breast, lung, and stomach. Its unique formulation provides a powerful approach to cancer treatment.
Uses of Mitomycin C
Cancer Treatment: Indicated for the treatment of pancreatic, breast, lung, and stomach cancers.
Combination Therapy: Can be utilized alone or alongside other chemotherapeutic agents to enhance therapeutic efficacy.
Benefits of Mitomycin C
Cancer Cell Inhibition: Effectively disrupts the growth of cancer cells, leading to their eventual destruction.
Tailored Treatment: Dosage and treatment frequency are individualized based on the patient's specific condition.
Mechanism of Action of Mitomycin C
Mitomycin C functions by interfering with the DNA synthesis of cancer cells, thereby inhibiting their growth and promoting apoptosis (programmed cell death). This targeted approach enhances its effectiveness in oncology.